PDE4D and breast cancer: We observed a sharp decrease in the levels of PDE4D upon treatment of ER+ breast cancer cells with SOC that accompanies increased PKA phosphorylation and reduced RB phosphorylation (Figs. 1f, 3a, b, Supplementary Fig. 1g).